Inventor · disambiguated record
Shuk-Man Ka
Also filed as: KA SHUK-MAN
16 granted patents·9 pending applications·7 citations·filing 2009–2023
86Inventor score
Top patents by PatentIndex Score
25 records- 0182US10172876B2Use of ginsenoside M1 for treating IgA nephropathyLEE SHEAU LONG·Filed 2015·Granted Jan 8, 2019·2 cites·6 claims
- 0280US9844560B2Use of ginsenoside M1 for treating lupus nephritisLEE SHEAU-LONG·Filed 2015·Granted Dec 19, 2017·4 cites·5 claims
- 0372US12478632B2Method for ameliorating progression of renal fibrosis and treating renal fibrosis by 5-(2′,4′-difluorophenyl)-salicylanilide derivativesNATIONAL DEFENSE MEDICAL UNIV·Filed 2023·Granted Nov 25, 2025·0 cites·9 claims
- 0468US9393226B2Use of osthole for treating focal segmental glomerulosclerosisNAT DEFENSE MEDICAL CT·Filed 2015·Granted Jul 19, 2016·1 cites·3 claims
- 0561US12000841B2Diagnostic kits and methods configured to rapidly and non-invasively determine physiologic levels of galactose-deficient IgA1 (Gd-IgA1) in the subject of IgA nephropathyNAT DEFENSE MEDICAL CENTER·Filed 2020·Granted Jun 4, 2024·0 cites·6 claims
- 0661US2023400468A1Human IgG autoantibodies against galactose-deficient IgA1, preparation method thereof, and use thereofNAT DEFENSE MEDICAL CENTER·Filed 2023·Application pending·0 cites
- 0760US2022354872A1Pharmaceutical composition and use thereof for relieving progression of chronic kidney disease or preventing thereofNAT DEFENSE MEDICAL CENTER·Filed 2021·Application pending·0 cites
- 0857US8329651B2Method for renal disease diagnosis and prognosis using annexin A1 and Rab23 as markersCHEN ANN·Filed 2009·Granted Dec 11, 2012·0 cites·8 claims
- 0956US2022275106A1Mouse monoclonal antibodies against galactose-deficient iga1,preparation method thereof, and use thereofNAT DEFENSE MEDICAL CENTER·Filed 2022·Application pending·0 cites
- 1055US8329410B2Method for diagnosing kidney disease comprising detecting the level of annexin A2CHEN ANN·Filed 2009·Granted Dec 11, 2012·0 cites·9 claims
- 1155US2012196287A1Tmsb4 as a Biomarker for IgA NephropathyCHEN ANN·Filed 2012·Application pending·0 cites
- 1254US8178358B2Serpine2 as a biomarker for IgA nephropathyCHEN ANN·Filed 2010·Granted May 15, 2012·0 cites·5 claims
- 1351US8785137B2Method for renal disease diagnosis using Rab23 as markerCHEN ANN·Filed 2010·Granted Jul 22, 2014·0 cites·3 claims
- 1451US2013101998A1Method for diagnosing kidney disease comprising detecting the level of annexin a2 or s100a6CHEN ANN·Filed 2012·Application pending·0 cites
- 1550US12090132B2Tris DBA pharmaceutical composition and its use for treating autoimmune diseasesNAT DEFENSE MEDICAL CENTER·Filed 2020·Granted Sep 17, 2024·0 cites·4 claims
- 1650US8993637B2Use of citral for treating focal segmental glomerulosclerosisNAT DEFENSE MEDICAL CT·Filed 2014·Granted Mar 31, 2015·0 cites·5 claims
- 1749US2015005390A1Method for treating inflammatory disorderNAT DEFENSE MEDICAL CT·Filed 2013·Application pending·0 cites
- 1848US9321795B2Use of hydroxycinnamaldehyde glycoside derivatives for treating glomerulonephritisNAT DEFENSE MEDICAL CT·Filed 2015·Granted Apr 26, 2016·0 cites·9 claims
- 1948US2015104881A1Sglt2 as biomarker for diagnosing chronic kidney disease and monitoring the disease status after treatmentNAT DEFENSE MEDICAL CT·Filed 2014·Application pending·0 cites
- 2045US9475789B2Use of polyenylpyrrole derivatives for treating inflammationLEE YU-CHIEH·Filed 2014·Granted Oct 25, 2016·0 cites·16 claims
- 2145US9295705B2Treatment for nephritisCHEN ANN·Filed 2011·Granted Mar 29, 2016·0 cites·16 claims
- 2243US2013323750A1Method for Analyzing Apoptosis Inducing Factor-2UNIV NAT TAIWAN HOSPITAL·Filed 2013·Application pending·0 cites
- 2342US8518461B2Use of bamboo vinegar for treating inflammationCHEN ANN·Filed 2012·Granted Aug 27, 2013·0 cites·4 claims
- 2441US10357507B2Use of ginsenoside M1 for inhibiting renal fibrosisLEE SHEAU LONG·Filed 2015·Granted Jul 23, 2019·0 cites·5 claims
- 2534US2012309821A1Use of epigallocatechin-3-gallate for immune regulationCHEN ANN·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →